Watson, Sandoz settle Medicaid whistleblower suits for $145M

Watson Pharmaceuticals ($WPI) and Novartis' ($NVS) generics unit Sandoz have agreed to settle False Claims Act lawsuits alleging  they overstated the prices on drugs sold to Medicaid programs. Watson agreed to pay $79 million, and Sandoz will cough up $66 million. Report